Baclofen intrathecal trial
Products billed under this code include Baclofen, Gablofen, Lioresal.
Payment limit per 50 MCG, by effective quarter, 1Q21 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.Products billed under this code include Baclofen, Gablofen, Lioresal.
Payment limit per 50 MCG, by effective quarter, 1Q21 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.From the 4Q26 NDC–HCPCS crosswalk. “Limit / pkg” is the 4Q26 payment limit times the billing units in one package.
| Product | Labeler | NDC | Units / pkg | Limit / pkg |
|---|---|---|---|---|
| Baclofen | Sagent Pharmaceuticals | 25021-0681-71 | 2 | $93.078 |
| Gablofen | Piramal Critical Care Inc | 66794-0151-01 | 1 | $46.539 |
| Lioresal | Amneal Pharmaceuticals, LLC | 70121-2496-05 | 5 | $232.695 |
| Quarter | Payment limit | Change | Billing unit | Description | Source file |
|---|---|---|---|---|---|
| 4Q26 | $46.539 | +$2.699 | 50 MCG | Baclofen intrathecal trial | v1, posted September 17, 2026 |
| 3Q26 | $43.84 | −$10.498 | 50 MCG | Baclofen intrathecal trial | v1, posted September 15, 2026 |
| 2Q26 | $54.338 | −$5.176 | 50 MCG | Baclofen intrathecal trial | v1, posted September 15, 2026 |
| 1Q26 | $59.514 | +$9.562 | 50 MCG | Baclofen intrathecal trial | v1, posted September 15, 2026 |
| 4Q25 | $49.952 | −$17.251 | 50 MCG | Baclofen intrathecal trial | v1, posted September 8, 2026 |
| 3Q25 | $67.203 | +$13.384 | 50 MCG | Baclofen intrathecal trial | v1, posted March 10, 2026 |
| 2Q25 | $53.819 | +$13.091 | 50 MCG | Baclofen intrathecal trial | v1, posted March 10, 2026 |
| 1Q25 | $40.728 | −$2.824 | 50 MCG | Baclofen intrathecal trial | v1, posted December 19, 2025 |
| 4Q24 | $43.552 | −$8.869 | 50 MCG | Baclofen intrathecal trial | v1, posted June 11, 2025 |
| 3Q24 | $52.421 | −$5.492 | 50 MCG | Baclofen intrathecal trial | v1, posted June 11, 2025 |
| 2Q24 | $57.913 | +$20.469 | 50 MCG | Baclofen intrathecal trial | v1, posted March 11, 2025 |
| 1Q24 | $37.444 | −$9.477 | 50 MCG | Baclofen intrathecal trial | v1, posted December 19, 2024 |
| 4Q23 | $46.921 | +$1.955 | 50 MCG | Baclofen intrathecal trial | v1, posted October 10, 2024 |
| 3Q23 | $44.966 | −$16.527 | 50 MCG | Baclofen intrathecal trial | v1, posted June 5, 2024 |
| 2Q23 | $61.493 | +$1.795 | 50 MCG | Baclofen intrathecal trial | v1, posted February 23, 2024 |
| 1Q23 | $59.698 | +$6.229 | 50 MCG | Baclofen intrathecal trial | v1, posted December 6, 2023 |
| 4Q22 | $53.469 | −$3.755 | 50 MCG | Baclofen intrathecal trial | v1, posted June 22, 2023 |
| 3Q22 | $57.224 | −$7.172 | 50 MCG | Baclofen intrathecal trial | v1, posted June 9, 2023 |
| 2Q22 | $64.396 | −$8.663 | 50 MCG | Baclofen intrathecal trial | v1, posted December 14, 2022 |
| 1Q22 | $73.059 | +$12.787 | 50 MCG | Baclofen intrathecal trial | v1, posted June 8, 2022 |
| 4Q21 | $60.272 | +$1.818 | 50 MCG | Baclofen intrathecal trial | v1, posted June 2, 2022 |
| 3Q21 | $58.454 | +$1.393 | 50 MCG | Baclofen intrathecal trial | v1, posted June 2, 2022 |
| 2Q21 | $57.061 | +$0.398 | 50 MCG | Baclofen intrathecal trial | v1, posted March 1, 2022 |
| 1Q21 | $56.663 | – | 50 MCG | Baclofen intrathecal trial | v1, posted December 10, 2021 |
“Change” is the difference from the previous quarter, shown only when both quarters have a payment limit and the billing unit is the same. “vs. last quarter” and “vs. a year ago” follow the same rule.